1. shona7993hibs
2. indigomoondrops
3. emmridethecat
4. ginsky
5. poboyboater
1.ginsky 06/15/2018
Epizyme Reports Positive Updated Interim Data from Phase 2 Study of Tazemetostat in Patients With Relapsed or Refractory Follicular Lymphoma at the Congress of the European Hematology Association (EHA
2.shona7993hibs 04/24/2018
Why... we are tanking
3.indigomoondrops 01/26/2018
love on news - Jefferies resumes as a buy, $25PT
4.shona7993hibs 06/03/2018
Epizyme Presents Encouraging Phase 2 Data of Tazemetostat for Malignant Mesothelioma at ASCO
5.poboyboater 04/24/2018
Epizyme Provides Update Regarding Tazemetostat Clinical Program
6.shona7993hibs 04/23/2018
Announced that U.S.-based enrollment of new patients
7.indigomoondrops 02/01/2018
Roth Capital
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW